111 Capital Has $237,000 Stake in GE HealthCare Technologies Inc. $GEHC

Key Points

• 111 Capital significantly reduced its stake in GE HealthCare Technologies by 88.9% in Q2, owning 3,201 shares worth $237,000 after selling 25,551 shares.
• Several other institutional investors have also shifted their holdings, with NBC Securities and Merit Financial Group acquiring new positions and increasing stakes, respectively.
• GE HealthCare has a consensus rating of "Moderate Buy" among analysts, with an average target price of $86.89, despite a recent downgrade from Wall Street Zen.

111 Capital cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 88.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,201 shares of the company's stock after selling 25,551 shares during the period. 111 Capital's holdings in GE HealthCare Technologies were worth $237,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NBC Securities Inc. bought a new position in shares of GE HealthCare Technologies during the first quarter worth about $43,000. Merit Financial Group LLC boosted its position in GE HealthCare Technologies by 16.0% during the 1st quarter. Merit Financial Group LLC now owns 10,232 shares of the company's stock worth $826,000 after acquiring an additional 1,412 shares during the last quarter. Procyon Advisors LLC grew its stake in shares of GE HealthCare Technologies by 78.2% during the 1st quarter. Procyon Advisors LLC now owns 4,992 shares of the company's stock worth $403,000 after acquiring an additional 2,191 shares in the last quarter. Orrstown Financial Services Inc. acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at approximately $202,000. Finally, Wedmont Private Capital lifted its position in shares of GE HealthCare Technologies by 7.0% in the first quarter. Wedmont Private Capital now owns 6,068 shares of the company's stock worth $490,000 after purchasing an additional 395 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Citigroup lifted their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. Seven research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $86.89.

GE HealthCare Technologies Trading Down 0.2%

Shares of NASDAQ:GEHC opened at $76.41 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The company has a market capitalization of $34.89 billion, a P/E ratio of 15.66, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13. The company has a 50-day simple moving average of $74.22 and a 200 day simple moving average of $72.44.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the company earned $1.00 earnings per share. The business's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.